These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2649351)

  • 21. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
    Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
    Schlenk RF; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G
    J Clin Oncol; 2004 Sep; 22(18):3741-50. PubMed ID: 15289486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostics and therapy of acute myeloid leukemia].
    Fritsch S; Metzeler K; Hiddemann W; Buske C
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia.
    Mollee P; Gupta V; Song K; Reddy V; Califaretti N; Tsang R; Crump M; Keating A
    Bone Marrow Transplant; 2004 Jun; 33(12):1201-8. PubMed ID: 15094745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute myeloid leukemia].
    Büchner T
    Internist (Berl); 1993 Jun; 34(6):511-7. PubMed ID: 8335440
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
    Gale RP; Butturini A
    Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
    [No Abstract]   [Full Text] [Related]  

  • 27. Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Jerjis S; Roovers E; Muus P; Schaap N; de Witte T
    Bone Marrow Transplant; 1998 Jul; 22(1):13-9. PubMed ID: 9678790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
    Chang J; Morgenstern GR; Coutinho LH; Scarffe JH; Carr T; Deakin DP; Testa NG; Dexter TM
    Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow transplantation in leukemia: experience of Pesaro.
    Galimberti M; Polchi P; Delfini C; Angelucci E; Baronciani D; Giardini C; Manenti F; Politi P; Lucarelli G
    Acta Haematol; 1987; 78 Suppl 1():187-9. PubMed ID: 3124445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of childhood acute myeloid leukaemia.
    Taub JW; Ravindranath Y
    Baillieres Clin Haematol; 1996 Mar; 9(1):129-46. PubMed ID: 8730554
    [No Abstract]   [Full Text] [Related]  

  • 31. Uterine infiltration as first sign of acute myeloid leukemia.
    Matthes T; Collao C; Samii K; Chapuis B; Girardet C; Diebold-Berger S
    Am J Hematol; 1999 Mar; 60(3):253-4. PubMed ID: 10072130
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of acute leukemia.
    Lechner K; Geissler K; Jäger U; Greinix H; Kalhs P
    Ann Oncol; 1999; 10 Suppl 6():45-51. PubMed ID: 10676552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The current status of therapy for and prevention of blast crisis of chronic myelocytic leukemia.
    Wiernik PH
    J Clin Oncol; 1984 Apr; 2(4):329-35. PubMed ID: 6368762
    [No Abstract]   [Full Text] [Related]  

  • 34. The treatment of acute leukaemia.
    Burnett AK; Eden OB
    Lancet; 1997 Jan; 349(9047):270-5. PubMed ID: 9014927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of resistant acute myeloid leukemia.
    Schiller G
    Blood Rev; 1991 Dec; 5(4):220-6. PubMed ID: 1782481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy of secondary leukemia.
    Rowe JM
    Leukemia; 2002 Apr; 16(4):748-50. PubMed ID: 11960361
    [No Abstract]   [Full Text] [Related]  

  • 37. Two secondary malignancies following the successful treatment of a patient with acute lymphoblastic leukemia.
    Garcia-Boyero R; Sanz GF; Sanz MA
    Ann Oncol; 1996 Mar; 7(3):322-3. PubMed ID: 8740801
    [No Abstract]   [Full Text] [Related]  

  • 38. Wider benefits of leukodepletion of blood products.
    Copplestone JA; Williamson P; Norfolk DR; Morgenstern GR; Wimperis JZ; Williamson LM
    Blood; 1995 Jul; 86(1):409-10. PubMed ID: 7795251
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of acute myeloid leukemia.
    Kanda Y; Miwa A; Togawa A
    N Engl J Med; 1999 May; 340(18):1436; author reply 1438. PubMed ID: 10328701
    [No Abstract]   [Full Text] [Related]  

  • 40. Does more intensive treatment cure more patients with acute myeloid leukemia? The BGMT Group.
    Reiffers J; Maraninchi D; Rigal-Huguet F; Michallet M; Marit G; Stoppa AM; Attal M; Hollard D
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):90-2. PubMed ID: 1780761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.